Literature DB >> 29976673

Mouse Norovirus Infection Reduces the Surface Expression of Major Histocompatibility Complex Class I Proteins and Inhibits CD8+ T Cell Recognition and Activation.

Svenja Fritzlar1, Sinthujan Jegaskanda1, Turgut Esad Aktepe1, Julia Emiley Prier1, Lauren Elise Holz1, Peter A White2, Jason M Mackenzie3.   

Abstract

Human noroviruses are highly infectious single-stranded RNA (ssRNA) viruses and the major cause of nonbacterial gastroenteritis worldwide. With the discovery of murine norovirus (MNV) and the introduction of an effective model for norovirus infection and replication, knowledge about infection mechanisms and their impact on the host immune response has progressed. A major player in the immune response against viral infections is the group of major histocompatibility complex (MHC) class I proteins, which present viral antigen to immune cells. We have observed that MNV interferes with the antigen presentation pathway in infected cells by reducing the surface expression of MHC class I proteins. We have shown that MNV-infected dendritic cells or macrophages have lower levels of surface expression of MHC class I proteins than uninfected and bystander cells. Transcriptional analysis revealed that this defect is not due to a decreased amount of mRNA but is reflected at the protein level. We have determined that this defect is mediated via the MNV NS3 protein. Significantly, treatment of MNV-infected cells with the endocytic recycling inhibitor dynasore completely restored the surface expression of MHC class I proteins, whereas treatment with the proteasome inhibitor MG132 partly restored such expression. These observations indicate a role for endocytic recycling and proteasome-mediated degradation of these proteins. Importantly, we show that due to the reduced surface expression of MHC class I proteins, antigen presentation is inhibited, resulting in the inability of CD8+ T cells to become activated in the presence of MNV-infected cells.IMPORTANCE Human noroviruses (HuNoVs) are the major cause of nonbacterial gastroenteritis worldwide and impose a great burden on patients and health systems every year. So far, no antiviral treatment or vaccine is available. We show that MNV evades the host immune response by reducing the amount of MHC class I proteins displayed on the cell surface. This reduction leads to a decrease in viral antigen presentation and interferes with the CD8+ T cell response. CD8+ T cells respond to foreign antigen by activating cytotoxic pathways and inducing immune memory to the infection. By evading this immune response, MNV is able to replicate efficiently in the host, and the ability of cells to respond to consecutive infections is impaired. These findings have a major impact on our understanding of the ways in which noroviruses interact with the host immune response and manipulate immune memory.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  CD8+ T cells; MHC I protein; antigen presentation; immune evasion; mouse norovirus

Mesh:

Substances:

Year:  2018        PMID: 29976673      PMCID: PMC6146715          DOI: 10.1128/JVI.00286-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States.

Authors:  Rebecca L Fankhauser; Stephan S Monroe; Jacqueline S Noel; Charles D Humphrey; Joseph S Bresee; Umesh D Parashar; Tamie Ando; Roger I Glass
Journal:  J Infect Dis       Date:  2002-06-10       Impact factor: 5.226

2.  CTL response compensation for the loss of an immunodominant class I-restricted HSV-1 determinant.

Authors:  Angus T Stock; Claerwen M Jones; William R Heath; Francis R Carbone
Journal:  Immunol Cell Biol       Date:  2006-09-05       Impact factor: 5.126

Review 3.  Proteasomes and their associated ATPases: a destructive combination.

Authors:  David M Smith; Nadia Benaroudj; Alfred Goldberg
Journal:  J Struct Biol       Date:  2006-05-08       Impact factor: 2.867

4.  Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

Authors:  J Levitskaya; A Sharipo; A Leonchiks; A Ciechanover; M G Masucci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

Review 5.  The epidemiology of published norovirus outbreaks: a review of risk factors associated with attack rate and genogroup.

Authors:  J E Matthews; B W Dickey; R D Miller; J R Felzer; B P Dawson; A S Lee; J J Rocks; J Kiel; J S Montes; C L Moe; J N S Eisenberg; J S Leon
Journal:  Epidemiol Infect       Date:  2012-03-26       Impact factor: 2.451

6.  Norwalk virus infection of volunteers: new insights based on improved assays.

Authors:  D Y Graham; X Jiang; T Tanaka; A R Opekun; H P Madore; M K Estes
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

7.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

8.  Enteric bacteria promote human and mouse norovirus infection of B cells.

Authors:  Melissa K Jones; Makiko Watanabe; Shu Zhu; Christina L Graves; Lisa R Keyes; Katrina R Grau; Mariam B Gonzalez-Hernandez; Nicole M Iovine; Christiane E Wobus; Jan Vinjé; Scott A Tibbetts; Shannon M Wallet; Stephanie M Karst
Journal:  Science       Date:  2014-11-07       Impact factor: 47.728

9.  Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.

Authors:  K Ahn; T H Meyer; S Uebel; P Sempé; H Djaballah; Y Yang; P A Peterson; K Früh; R Tampé
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

10.  Coinfection. Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation.

Authors:  Lisa C Osborne; Laurel A Monticelli; Timothy J Nice; Tara E Sutherland; Mark C Siracusa; Matthew R Hepworth; Vesselin T Tomov; Dmytro Kobuley; Sara V Tran; Kyle Bittinger; Aubrey G Bailey; Alice L Laughlin; Jean-Luc Boucher; E John Wherry; Frederic D Bushman; Judith E Allen; Herbert W Virgin; David Artis
Journal:  Science       Date:  2014-07-17       Impact factor: 47.728

View more
  5 in total

Review 1.  [Composition and mode of action of adjuvants in licensed viral vaccines].

Authors:  Ralf Wagner; Eberhard Hildt
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

2.  Generation of Norovirus-Specific T Cells From Human Donors With Extensive Cross-Reactivity to Variant Sequences: Implications for Immunotherapy.

Authors:  Ryo Hanajiri; Gelina M Sani; Devin Saunders; Patrick J Hanley; Abha Chopra; Simon A Mallal; Stanislav V Sosnovtsev; Jeffrey I Cohen; Kim Y Green; Catherine M Bollard; Michael D Keller
Journal:  J Infect Dis       Date:  2020-02-03       Impact factor: 5.226

3.  Mapping the Key Residues within the Porcine Reproductive and Respiratory Syndrome Virus nsp1α Replicase Protein Required for Degradation of Swine Leukocyte Antigen Class I Molecules.

Authors:  Yuanyuan Liu; Peng Gao; Lei Zhou; Xinna Ge; Yongning Zhang; Xin Guo; Jun Han; Hanchun Yang
Journal:  Viruses       Date:  2022-03-26       Impact factor: 5.818

4.  The Microtubule-Associated Innate Immune Sensor GEF-H1 Does Not Influence Mouse Norovirus Replication in Murine Macrophages.

Authors:  Svenja Fritzlar; Peter A White; Jason M Mackenzie
Journal:  Viruses       Date:  2019-01-10       Impact factor: 5.048

Review 5.  Immune Response Modulation by Caliciviruses.

Authors:  Yoatzin Peñaflor-Téllez; Adrian Trujillo-Uscanga; Jesús Alejandro Escobar-Almazán; Ana Lorena Gutiérrez-Escolano
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.